LMO1 and non-small cell lung carcinoma: Coupled with our in vitro findings that LMO1 functions to promote growth of lung cancer cells, our results support LMO1 expression as a functional oncogenic and prognostic biomarker for neuroendocrine differentiation of NSCLC.